Literature DB >> 15505986

Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer.

S Lisi1, F Menconi, M A Altea, L Agate, E Molinaro, M G Castagna, D Taddei, L Grasso, A Pinchera, R Elisei, M Marinò.   

Abstract

When thyroid follicles are intact, some colloidal thyroglobulin (Tg) reaches the circulation by megalin-mediated transcytosis and is to various extents complexed with megalin secretory components. In contrast, in papillary thyroid cancer (PTC), serum Tg is not complexed with megalin because it is directly secreted by tumor cells. Here we attempted to use measurement of megalin secretory components to distinguish PTC patients with thyroid remnant plus metastases from those with thyroid remnant only, after thyroidectomy and before 131I ablation. Tg values in anti-Tg antibodies (TgAb)-free sera from 5 PTC patients with thyroid remnant plus metastases and 12 PTC patients with thyroid remnant only were measured following pre-adsorption with uncoupled protein A beads or with protein A beads coupled with antimegalin antibodies. The degree of Tg pre-adsorption with antimegalin antibodies was minimal, with no substantial differences between the two groups. Thus, we concluded that measurement of megalin secretory components is unlikely to be useful to identify the origin of serum Tg in PTC patients after thyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505986     DOI: 10.1007/BF03347495

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  Megalin in thyroid physiology and pathology.

Authors:  M Marinò; A Pinchera; R T McCluskey; L Chiovato
Journal:  Thyroid       Date:  2001-01       Impact factor: 6.568

2.  Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.

Authors:  L Druetta; H Bornet; G Sassolas; B Rousset
Journal:  Eur J Endocrinol       Date:  1999-05       Impact factor: 6.664

3.  Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release.

Authors:  M Marinò; G Zheng; L Chiovato; A Pinchera; D Brown; D Andrews; R T McCluskey
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

4.  Circulating thyroglobulin transcytosed by thyroid cells in complexed with secretory components of its endocytic receptor megalin.

Authors:  M Marinò; L Chiovato; N Mitsiades; F Latrofa; D Andrews; S Tseleni-Balafouta; A B Collins; A Pinchera; R T McCluskey
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

5.  Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.

Authors:  M Schlumberger; E Baudin
Journal:  Eur J Endocrinol       Date:  1998-03       Impact factor: 6.664

Review 6.  Serum and tissue thyroglobulin measurement: clinical applications in thyroid disease.

Authors:  F Pacini; A Pinchera
Journal:  Biochimie       Date:  1999-05       Impact factor: 4.079

7.  Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.

Authors:  F Pacini; L Agate; R Elisei; M Capezzone; C Ceccarelli; F Lippi; E Molinaro; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

8.  Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release.

Authors:  Simonetta Lisi; Aldo Pinchera; Robert T McCluskey; Thomas E Willnow; Samuel Refetoff; Claudio Marcocci; Paolo Vitti; Francesca Menconi; Lucia Grasso; Fabiana Luchetti; A Bernard Collins; Michele Marino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

Authors:  F Pacini; F Lippi; N Formica; R Elisei; S Anelli; C Ceccarelli; A Pinchera
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

10.  Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP).

Authors:  G Zheng; D R Bachinsky; I Stamenkovic; D K Strickland; D Brown; G Andres; R T McCluskey
Journal:  J Histochem Cytochem       Date:  1994-04       Impact factor: 2.479

View more
  1 in total

1.  Kidney abnormalities in low density lipoprotein receptor associated protein knockout mice.

Authors:  S Lisi; R Botta; A Pinchera; A Bernard Collins; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.